Larry N. Feinberg 13D/13G Filings for Soleno Therapeutics, Inc. (SLNO)

Larry N. Feinberg 13D and 13G filings for Soleno Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
4:02 pm
Sale
2020-12-3113GSoleno Therapeutics, Inc.
SLNO
Larry N. Feinberg248,843
4.700%
-131,160decrease
(-34.52%)
Filing